Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

Summary

This will be an open-label, single-dose, non-randomized, five-period crossover study in healthy volunteers. The duration of the study will last up to eleven weeks from screening to follow-up. PK samples will be taken.

Timeline

Start

2007-10

Primary completion

2007-12

Completion

2007-12

Drugs

Indications